Long-term nitric oxide synthase inhibition in rat pregnancy reduces renal kallikrein

Hypertension

Volumn 34, Issue 4 II, 1999, Pages 865-871

  Salas, Sofía P ^a   Vuletin, José F ^a   Giacaman, Andrea ^a   Rosso, Pedro ^a   Vío, Carlos P ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Macrophages; Nitric oxide; Plasma renin activity; Pregnancy; Renal kallikrein; Renal lesions

Indexed keywords

KALLIKREIN; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; RENIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; ENZYME INHIBITION; FEMALE; FETUS WEIGHT; KALLIKREIN KININ SYSTEM; KALLIKREIN URINE LEVEL; NONHUMAN; PLACENTA; PLASMA RENIN ACTIVITY; PREGNANCY; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0032754044     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.34.4.865     Document Type: Article

References (36)

1. Longo LD. Maternal blood volume and cardiac output during pregnancy: a hypothesis of endocrinologic control. Am J Physiol. 1983;245: R720-R729.
2. Wilson M, Morganti AA, Zervoudakis I, Letcher R, Romney B, Von Oeyon P, Papera S, Sealey J, Laragh J. Blood pressure, the renin-aldosterone system and sex steroids throughout normal pregnancy. Am J Med. 1980;68:97-104.
3. Schrier RW, Briner VA. Peripheral arterial vasodilation hypothesis of sodium and water retention in pregnancy: implications for pathogenesis of preeclampsia-eclampsia. Obstet Gynecol. 1991;77:632-639.
4. Salas SP, Roblero JS, Croxatto HR, Valdés G. Urinary kallikrein activity during rat pregnancy. Arch Biol Med Exp. 1987;20:305-309.
5. Salas SP, Rosso P, Espinoza R, Robert JA, Valdés G, Donoso E. Maternal plasma volume expansion and hormonal changes in women with idiopathic fetal growth retardation. Obstet Gynecol. 1993;81:1029-1033.
6. Salas SP, Rosso P. Plasma volume, renal function, and hormonal levels in pregnant women with idiopathic fetal growth restriction or preeclampsia. Hypertens Pregnancy. 1998;17:69-79.
7. Rosso P, Salas SP, Mechanisms of fetal growth retardation in the underweight mother. In: Allen L, King J, Lönnerdal B, eds. Nutrient Regulation During Pregnancy, Lactation, and Infant Growth. New York, NY:. Plenum Press; 1994:1-9.
8. Conrad KP, Vernier KA. Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. Am J Physiol. 1989;257: R847-R853.
9. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JE, Mosher MD. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J. 1993;7:566-571.
10. Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol. 1997;272:R441-R463.
11. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 1992;90:278-281.
12. Molnár M, Sütö T, Tóth T, Hertelendy F. Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol. 1994;170:1458-1466.
13. Yallampalli C, Garfield RE. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol. 1993;169:1316-1320.
14. Salas SP, Altermatt F, Campos M, Giacaman A, Rosso P. Effects of long-term nitric oxide synthesis inhibition on plasma volume expansion and fetal growth in the pregnant rat. Hypertension. 1995;26:1019-1023.
15. Helmbrecht GD, Farhat MY, Lochbaum L, Brown HE, Yadgarova KT, Eglinton GS, Ramwell PW. L-Arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am J Obstet Gynecol. 1996;175:800-805.
16. Amundsen E, Putter J, Friberger P, Knos M, Larsbraten M, Claeson G. Methods for determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Adv Exp Med Biol. 1979;120:83-95.
17. Velarde V, Humphreys J, Figueroa CD, Vío CP. Postnatal maturation of tissue kallikrein-producing cells (connecting tubule cells) in the rat kidney: a morphometric and immunohistochemical study. Anat Embryol. 1995;192:407-414.
18. Sternberger LA, Sternberger NH. The unlabeled antibody method: comparison of peroxidase-antiperoxidase with avidin-biotin complex by a new method of quantification. J Histochem Cytochem. 1986;34:599-605.
19. Bhoola KD, Figueroa CD, Worthy K. Bioregulation of kinins: kallikreins, kininogens and kininases. Pharmacol Rev. 1992;44:1-80.
20. Barajas L, Powers K, Carretero OA, Scicli AG, Inagami T. Immunocytochemical localization of renin and kallikrein in the rat renal cortex. Kidney Int. 1986;29:965-970.
21. Vío CP, Figueroa CD, Caorsi I. Anatomical relationship between kallikrein containing tubules and the juxtaglomerular apparatus in the human kidney. Am J Hypertens. 1988;1:269-272.
22. Vío CP, Figueroa CD. Subcellular localization of renal kallikrein by ultrastructural immunocytochemistry. Kidney Int. 1985;28:36-42.
23. Abe M, Nakamura F, Tan F, Deddish PA, Colley KJ, Becker RP, Skidgel RA, Erdös EG. Expression of rat kallikrein and epithelial polarity in transfected Madin-Darby canine kidney cells. Hypertension. 1995;26: 891-898.
24. Jaffa AA, Vío CP, Silva RH, Vavrek RJ, Stewart JM, Rust PF. Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat. J Clin Invest. 1992;89:1460-1468.
25. Bierwaltes WH, Prada J, Carretero OA. Kinin stimulation of renin release in isolated rat glomeruli. Am J Physiol. 1985;248:F757-F761.
26. Tolins JP, Raij L. Effects of amino acid infusion on renal hemodynamics: role of endothelium-derived relaxing factor. Hypertension. 1991;17: 1045-1051.
27. Chao C, Madeddu P, Wang C, Liang Y, Chao L, Chao J. Differential regulation of kallikrein, kininogen, and kallikrein-binding protein in arterial hypertensive rats. Am J Physiol. 1996;271(Renal Fluid Electrolyte Physiol 40)(1 Pt 2):F78-F86.
28. Dananberg J, Sider R, Grekin R. Sustained hypertension induced by orally administered nitro-L-arginine. Hypertension. 1993;21:359-363.
29. Schricker K, Hegyi I, Hamann M, Kaissling B, Kurtz A. Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II. Proc Natl Acad Sci U S A. 1995;92: 8006-8010.
30. Navarro J, Sanchez A, Saíz J, Ruilope LM, García-Están J, Romero JC, Moncada S, Lahera V. Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol. 1994;267:R1516-R1521.
31. Jaffa A, Vío C, Velarde V, LeRoith D, Mayfield R. Induction of renal kallikrein and renin gene expression by insulin and IGF-I in the diabetic rat. Diabetes. 1997;46:2049-2056.
32. Zatz R, Baylis C. Chronic nitric oxide inhibition model six years on. Hypertension. 1998;32:958-964.
33. Ito S, Carretero O, Abe K. Nitric oxide in the regulation of renal blood flow. New Horiz. 1995;3:615-623.
34. Lan H, Nikolic-Paterson D, Mu W, Atkins R. Local macrophage proliferation in the progression of glomerular and tubulointerstitial injury in rat anti-GBM glomerulonephritis. Kidney Int. 1995;48:753-760.
35. Salas SP. Role of nitric oxide in maternal hemodynamics and hormonal changes in pregnant rats. Biol Res. 1998;31:243-250.
36. Myatt L, Brewer A, Brockman DE. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol. 1991; 164:687-692.